METHODS FOR IDENTIFYING CANCER PATIENTS AT HIGH RISK OF DEVELOPING METASTASIS

Methods for identifying cancer patients at high risk of developing metastasis. The present invention relates to the field of biomedicine and cancer. Specifically, it relates to an in vitro method of prognosis or for predicting the risk of suffering from metastasis in a patient having localized cance...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GARCIA OLMO, Dolores C, OLMEDILLAS LOPEZ, Susana, PEIRO PASTOR, Ramón, GARCIA ARRANZ, Mariano, AGUADO OREA, Begoña, GARCIA OLMO, Damián
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Methods for identifying cancer patients at high risk of developing metastasis. The present invention relates to the field of biomedicine and cancer. Specifically, it relates to an in vitro method of prognosis or for predicting the risk of suffering from metastasis in a patient having localized cancer disease based on the differential presence of exons in circulating cell free DNA (cfDNA) in cancer patients. L'invention concerne des méthodes d'identification de patients cancéreux présentant un risque élevé de développer des métastases. La présente invention concerne le domaine de la biomédecine et du cancer. Spécifiquement, l'invention concerne une méthode in vitro de pronostic ou de prédiction du risque de souffrir de métastases chez un patient ayant une maladie cancéreuse localisée sur la base de la présence différentielle d'exons dans l'ADN acellulaire circulant (cfDNA) chez des patients cancéreux.